A respiratory syncytial virus vaccine, or RSV vaccine, is a vaccine that protects against respiratory syncytial virus. RSV affects an estimated 64 million people and causes 160,000 deaths worldwide each year. From Wikipedia
The pharmaceutical giant reports a drop in third-quarter sales due to decreased demand for its Arexvy vaccine, while growth in specialty medicines provides some relief.
